• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

ABR_Website_Image.jpg

— August 31, 2017

Valneva Reports Robust H1 2017 Financial Results & Major R&D Progress

Read more

— Stock information

@valnevase




















-
— July 26, 2017
Valneva and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus

Read more
— Financial Calendar

November 9, 2017
Q3 2017 Interim Results

See all dates






JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences


World Vaccine Congress Europe
Barcelona, Spain
October 10-12, 2017

Stifel Healthcare Conference
New York, US
November 14-15, 2017

Jefferies 2017 Global Healthcare Conference
London, UK
November 15-16, 2017

21st World Congress and Exhibition on Vaccines, Vaccination & Immunization

Vienna, Austria
November 16-17, 2017


 
Please update your browser...